40代ããå§ããã现èã®å€§æé€ãââèå鲿¢ã¹ã€ãããæŒãæå€ãªé£äºæ³3ã€ã§ãäœã®äžããè¥è¿ã
ãå¥åº·ã«æ°ãã€ããŠããã®ã«ããªããæè¿ã©ãã©ãèããŠããæ°ãããâŠã
æ¯æã¹ã ãŒãžãŒã飲ãã§ãã¿ã³ãã¯è³ªãæèããŠæã£ãŠã鿬 æé£ã詊ããŠã¿ããã§ãæããããªçµæãåºãªãããããç²ããåãã«ãããªã£ãããäœãéãæãããââã
ãããªçµéšããããŸãããïŒ
å®ã¯ã40代以éã®äœã«å¿ èŠãªé£äºæ³ã¯ã20ã30代ãšã¯æ ¹æ¬çã«éããŸãããããŠãã®éãã®æ žå¿ã«ããã®ãããªãŒããã¡ãžãŒããšããã现èã«åãã£ãèªå·±æµåã®ããã¿ã§ãã
仿¥ã¯ãäžççãªé·å¯¿ç ç©¶ãããšã«ã幎霢ãéããäœã«æ¬åœã«å¿ èŠãªé£äºæ³ã3ã€ãäŒãããŸããåžžèãèŠãå 容ããããŸãããæåŸãŸã§èªããšããªãã»ã©ãããããããšãããšãã£ããããã¯ãã§ãã
åèïŒ
åçåŽåçãæ¥æ¬äººã®é£äºæååºæºïŒ2025幎çïŒãç宿€èšäŒå ±åæžïŒ2024幎ïŒ
Clinical Nutrition 2025ãDawn-to-dusk intermittent fasting is associated with overexpression of autophagy genesã
Levine, Morgan E et al. "Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality" Cell Metabolism vol. 19,3 (2014): 407-17.
ãªãŒããã¡ãžãŒãšã¯äœãââ现èã«æèŒãããããªãµã€ã¯ã«å·¥å Žã
èåã®æ£äœã¯ã现èã®äžã®ãŽãæºãŸãã
ç§ãã¡ã®äœã®äžã§ã¯ãæ¯æ¥èšå€§ãªæ°ã®çްèãåããŠããŸããããã䜿ãå€ããã现èå ã®ã¿ã³ãã¯è³ªã现èå°åšå®ã¯ãæéãšãšãã«å£åããæå®³ãªåœ±é¿ãåãŒãããã«ãªããŸãã
ããããèåãã®æ£äœã®ã²ãšã€ã§ãã
ãšãããã人éã®äœã«ã¯ãã®èå»ç©ãèªåã§åè§£ã»åå©çšããæ©èœãåãã£ãŠããŸããããããªãŒããã¡ãžãŒã§ããã®ãªã·ã£èªã§ãèªåèªèº«ãé£ã¹ãããã€ãŸããèªé£ããæå³ãããã®æ©èœã¯ãæå·ããã¿ã³ãã¯è³ªã现èå°åšå®ãåã蟌ã¿ãåè§£ãã现èã®åæãšããŠåå©çšããŸããããã°ã现èå ã®ãªãµã€ã¯ã«å·¥å Žãã§ãã
2016幎ã«ãªãŒããã¡ãžãŒã®ç ç©¶ã§ããŒãã«ççåŠã»å»åŠè³ãåè³ãã倧é è¯å žææã®ç 究以æ¥ããã®æ©èœã¯äžççã«æ³šç®ãããŠãããèå鲿¢ã»ç æ°äºé²ãšã®é¢ä¿ã次ã ãšæããã«ãªã£ãŠããŸãã
ãªãçŸä»£äººã®äœã§ãªãŒããã¡ãžãŒãæ©èœããªãã®ã
ãªãŒããã¡ãžãŒã®ãã¹ã€ããããæ¡ã£ãŠããã®ããmTORïŒãšã ããŒã«ïŒè€åäœãšåŒã°ããã¿ã³ãã¯è³ªã§ãã
mTORã®ã¹ã€ããããªã³ã®ãšã â äœã¯ãæé·ã¢ãŒããïŒçްèãå¢ããã»æ é€ãèããïŒ
mTORã®ã¹ã€ããããªãã®ãšã â äœã¯ã修埩ã¢ãŒããïŒãªãŒããã¡ãžãŒãåãã»çްèãæµåããïŒ
åé¡ã¯ãçŸä»£äººã®é£ç掻ã§ã¯mTORã®ã¹ã€ãããã»ãŒ1æ¥äžãªã³ã«ãªã£ãŠãããšããããšã§ããäžé£ãã£ããé£ã¹ãŠãéé£ãããŠãã¿ã³ãã¯è³ªããã£ããšè£çµŠããââããã¯äœããæé·ã¢ãŒããã«çœ®ãç¶ããããšãæå³ããŸãã
ãéšå±ã«äŸãããšãæ¯æ¥å€é ããŸã§æ£ãããç¶ããŠãäžåºŠãæé€ã§ããŠããªãç¶æ ããã°ããã¯ãªããšããªã£ãŠããŠããããæ¥çªç¶ãæ¥ã«èããããšæããè¡°ããããŒã³ãšãã£ãŠããŸãã
æµåãšæé·ããã®ãµãã€ãããŸãåãæ¿ããããšãã40代以éã®å¥åº·ã®æéèŠããŒããªã®ã§ãã
mTORã¹ã€ãããåã3ã€ã®é£äºæ³
é£äºæ³â 鿬 çãã¡ã¹ãã£ã³ã°ïŒæé£ïŒââæ®µéçã«å§ããã®ãã³ã
16æéã®ç©ºè ¹æéãäœãããšã§ãªãŒããã¡ãžãŒã掻æ§åãããã16æéæé£ãã¯ããã§ã«å€ãã®æ¹ããåç¥ããšæããŸãã2025幎ã®å»åŠèªãClinical Nutritionãã«æ²èŒãããç ç©¶ã§ãã鿬 çæé£ããªãŒããã¡ãžãŒéºäŒåã®æŽ»æ§åãšé¢é£ããããšã瀺ãããŠããŸãã
ãããããããªã16æéæé£ã«ææŠããŠæ«æãã人ãåŸãçµ¶ã¡ãŸãããçç±ã¯ç¡çãªããæ¹ã«ãããŸãã
段éçãªå§ãæ¹
ãŸãæåã®ã¹ãããã¯ãå€7æä»¥éã«é£ã¹ãªããããšãå€7æã«é£äºãçµãããã®ãŸãŸå°±å¯ããŠç¿æ7æã«æé£ãæãã°ãããã ãã§12æéã®æé£ã宿ããŸãã
ãã®ãªãºã ã«æ £ããŠããããæ¬¡ã®ã¹ããããšããŠæé£ãæããæåã®é£äºã11ã12æã®æŒé£ã«ããŸããããã§èªç¶ã«16æéã®æé£ãéæã§ããŸãã
ãã€ã³ãã¯å€ã®é£äºãæ©ããããšããããŠãããªãæé£ãæããªãããšãé£ã¹ãŠãããã®ãçªç¶ããããšäœã«å€§ããªè² æ ãããããŸãã
ãªããæé£ã«ãã£ãŠè¡ç³å€ãäžãããããããšãå¿é ããæ¹ãããŸãããç©ºè ¹æã«ã¯ã°ã«ã«ãŽã³ãšãããã«ã¢ã³ãåæ³ãããè¡ç³å€ã®ãã©ã³ã¹ãä¿ã¡ãªãããªãŒããã¡ãžãŒã掻æ§åãããŸãã
ãªãŒããã¡ãžãŒã掻ãããµã€ã¯ã«ã®ç®å®
ç ç©¶è ã®éã§ã¯ã1幎ã®ãã¡3åã®2ïŒçŽ8ã¶æïŒã¯ãªãŒããã¡ãžãŒã掻æ§åãããæ®ã3åã®1ïŒçŽ4ã¶æïŒã¯äŒãŸããã®ãçæ³ãšãããŠããŸãã8ã¶æé£ç¶ã§ãªããŠããã2ã¶æãªã³ã»1ã¶æãªããã®ããã«çްåãã«ããŠãããŸããŸããã
é£äºæ³â¡ äœç³è³ªã»é«é£ç©ç¹ç¶é£ââã€ã³ã¹ãªã³ãåºãéããªãé£ã¹æ¹
mTORã®ã¹ã€ããããªã³ã«ããæå€§ã®èŠå ã®äžã€ãã€ã³ã¹ãªã³ã®éå°åæ³ã§ãã
ã€ã³ã¹ãªã³ã¯è¡ç³å€ãäžããæ é€ãèèªãçèã«è²¯èµããåãããããã«ã¢ã³ã§ãããåæã«mTORãæŽ»æ§åãããŸããã€ãŸãç³è³ªãå€ãæããšãã€ã³ã¹ãªã³ã倧éåæ³ãããäœããæé·ã¢ãŒããã«å ¥ãããªãŒããã¡ãžãŒãåããªããªãã®ã§ãã
å®è·µã®ãã€ã³ã
粟補ãããç³è³ªïŒçœç±³ã»çœããã³ã»ç ç³ïŒãæžãã
é£ç©ç¹ç¶ãè±å¯ãªéèãé£äºã®äžå¿ã«ãã
ç©ç©ããäœãããé£åã¯ã§ããã ãæ§ãã
åçåŽåçãæ¥æ¬äººã®é£äºæååºæºïŒ2025幎çïŒãã§ããé£ç©ç¹ç¶ã®çæ³æåéãæäºº1æ¥25gã«åŒãäžããŠãããé£ç©ç¹ç¶ãè±å¯ãªé£äºã»ã©ãããç³å°¿ç ãªã©ã®çæŽ»ç¿æ £ç ãªã¹ã¯ãäœããªãããšãææ°ã®ç ç©¶ã§ç€ºãããŠããŸãã
éèã䞻圹ã«ããŠãè¯è³ªãªè質ïŒãªã¡ã¬3èèªé žãè±å¯ãªéããã«ããã¢ããããªã©ïŒãçµã¿åãããé£äºã¹ã¿ã€ã«ãçæ³çã§ãã
é£äºæ³â¢ åç©æ§ã¿ã³ãã¯è³ªã®å¶éââãããæãæå€ãªèœãšã穎
ãã¿ã³ãã¯è³ªã¯ã©ãã ãæã£ãŠããããããããã€ã³ã¯æ¯æ¥é£²ãã¹ããââå¥åº·æ¥çã§ã¯ãããªæ å ±ãããµããŠããŸããã§ããç¹ã«40代以éã®æ¹ã«ãšã£ãŠããããæå€§ã®èœãšã穎ã«ãªãå¯èœæ§ããããŸãã
ã¿ã³ãã¯è³ªéå°æåã®4ã€ã®ãªã¹ã¯
è èãžã®è² æ ïŒã¿ã³ãã¯è³ªã代è¬ããéã«çããçªçŽ ãåŠçãããããè èãéå°ã«åãç¶ããŸããäœéÃ1.3g/æ¥ãè¶ ããªããããæ¥æ¬è èåŠäŒã泚æãä¿ããŠããŸã
å¿è¡ç®¡çŸæ£ãªã¹ã¯ã®äžæïŒèµ€èº«èãé·æé倧éã«æåãç¶ãããšãå¿èç ã«é¢é£ããç©è³ªãäœå ã§å¢å ããããšãç ç©¶ã§æããã«ãªã£ãŠããŸã
ãããªã¹ã¯ãšã®é¢ä¿ïŒIGF-1ïŒã€ã³ã¹ãªã³æ§æé·å å-1ïŒãéå°ã«ãªããšããã现èã®å¢æ®ãä¿ãå¯èœæ§ãææãããŠãããä¹³ããã»å€§è žããã»åç«è ºãããšã®é¢é£ãç ç©¶ãããŠããŸã
代è¬é害ã®ãªã¹ã¯ïŒã¿ã³ãã¯è³ªã«ãç³è³ªã«è¿ãã€ã³ã¹ãªã³åæ³ãä¿ãäœçšããããéå°æåã¯ç³å°¿ç ãªã¹ã¯ãé«ããããšãããã£ãŠããŸã
ãªãã¿ã³ãã¯è³ªãå°ãæ§ãããšãªãŒããã¡ãžãŒã掻æ§åããã®ã
äœå ã®ã¿ã³ãã¯è³ªãäžè¶³ãããšãäœã¯ãå€ããªã£ãã¿ã³ãã¯è³ªãåè§£ããŠåå©çšãããããšåãåºããŸããããããªãŒããã¡ãžãŒãšåãã¡ã«ããºã ã§ããé©åãªã¿ã³ãã¯è³ªå¶éããäœå ã®èªå·±æµåãä¿ãã®ã§ãã
æ§ããã®ã¯ãåç©æ§ã¿ã³ãã¯è³ªã
éèŠãªã®ã¯ãå¶éãã¹ãã¯åç©æ§ã¿ã³ãã¯è³ªã ãšããç¹ã§ããéïŒç¹ã«ãªã¡ã¬3ãè±å¯ãªãã®ïŒã¯äŸå€ãšããŠãèã»ä¹³è£œåã»åµãªã©ã®éå°æåãèŠçŽãããšãæšå¥šãããŠããŸãã
ãŸãããã®é£äºæ³ã¯ãã¹ãŠã®äººã«åœãŠã¯ãŸãããã§ã¯ãããŸãããæé·æã®æ¹ãåŠåš äžã»æä¹³äžã®æ¹ã«ã¯ã¿ã³ãã¯è³ªãååã«å¿ èŠã§ãã幎霢ãéããæäººããéå°æåãèŠçŽããšããæèã§çè§£ããŠãã ããã
éåããªãŒããã¡ãžãŒã®ãã¹ã€ãããã«ãªã
é£äºæ³ãšäžŠãã§éèŠãªã®ãéåã§ããéåã¯ä»£è¬ã«é¢ããèåšã«é©åºŠãªåºæ¿ãäžãããªãŒããã¡ãžãŒã掻æ§åãããŸãã
ãã ããããããã¯é广ãç¹ã«æé žçŽ éåã®ç¿æ £ããªãæ¹ã¯ããŸãæ¯æ¥20åã®éåãç®æšã«ããã®ãããããã§ããé床ãªéåã¯ããã£ãŠäœã«ãã¡ãŒãžãäžããããšãç ç©¶ã§ç€ºãããŠããŸãã
ãŸãšãââ40代ããäœã®äžãæŽããé£äºã®3åå
粟補ç³è³ªãæžãããéèãé£äºã®äžå¿ã«ïŒã€ã³ã¹ãªã³ãéå°åæ³ããããmTORã®ã¹ã€ãããåãããããã
鿬 çãã¡ã¹ãã£ã³ã°ã段éçã«åãå ¥ããïŒå€7æä»¥éé£ã¹ãªãããšããå§ããæ £ããã16æéæé£ãž
åç©æ§ã¿ã³ãã¯è³ªããé©éãã«èŠçŽãïŒãªã¡ã¬3è±å¯ãªéã¯ç¶ããŠãèã»ä¹³è£œåã®éå°æåãæ§ãã
ãããã¯ãé£ã¹ãªãææ ¢ãã§ã¯ãªãããäœã®äžã®æµåãµã€ã¯ã«ãåãæ»ãããšããèãæ¹ã§ãã40代以éã®äœã¯æé·ãã修埩ã倧åãé£äºãå°ãèŠçŽãã ãã§ã现èã¬ãã«ããè¥è¿ãå¯èœæ§ããããŸãã
ãã²ä»æ¥ã®å€é£ãããå°ãã ãæèããŠã¿ãŠãã ããã
æåŸãŸã§èªãã§ããã ãããããšãããããŸãã
ãã®èšäºãåèã«ãªã£ããšæã£ãããã¹ããããé¡ãããŸãïŒ
ãã©ããŒãããã ãããšã¿ã€ã ã©ã€ã³ã«ãç¥ã£ãŠãã ãã§åŸããããããŒãã«æ°ããèšäºãæ¯æ¥å±ããŸãã
ããããé¡ãããŸãïŒ
次ã«èªããªã以äžðïžã®èšäºãããããã§ãã
#ãªãŒããã¡ãžãŒ #鿬 æé£ #æèåã±ã¢ #40代ã®é£äº #现èããè¥è¿ã #mTOR #èå鲿¢é£ #ã¿ã³ãã¯è³ªã®æãæ¹ #è žæŽ»ãšèå #å¥åº·é·å¯¿ã®é£äº
ãããªãšæã£ããå¿æŽãããïŒ
ãããããã°å¿æŽãé¡ãããŸãïŒ ããã ãããããã¯ã¯ãªãšã€ã¿ãŒãšããŠã®æŽ»åè²»ã«äœ¿ãããŠããã ããŸãïŒ